Market Research Logo

Advances in Cancer Therapy

394 Pages Kalorama Information February 01, 2001 SKU: KLI25

As we enter the 21st century, advances in the treatment of cancer will be significant and the patient will benefit in terms of quality of life. It is not unreasonable to anticipate a time when many cancer patients are managed as if they were chronically ill.

These thoughts are being shaped and driven by a variety of forces:

  • A new paradigm that would make use of the patient's natural immune and control systems
  • The vast array of developing knowledge in the area of cells
  • New products under development based on the immune system and cell function or death
  • Critical strategic alliances between researched-based pharmaceutical and biotech

This study focuses on the five key segments that will impact advanced cancer therapy:

  • Immunological and vaccine approaches
  • Antiproliferative approaches
  • Photodynamic therapy
  • Gene therapy approaches
  • Cell cycle and apoptosis approaches

The report provides detailed company profiles, which include:

  • Current products
  • Product pipeline
  • Key strategic alliances (large and small)
  • Discussions of the core technologies R&D activities

The study provides forecast information and examines selected dynamics and cancer statistics for the 7 major world markets.

Show Full Description

Show Table of Contents

download product sample

Search inside this report

Pricing & Delivery

Online Download

Didn't find what you are looking for?

Let us find it for you. One of our knowledgeable research assistants will work with you to find exactly the right research to answer your questions:

US: 800.298.5699 International: +1.240.747.3093 Or leave us a message and we'll call you back!

Receive bi-weekly email alerts for new market research.

CTA Image

Download our free eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download CTA

Share this report